- Home
- AVDL vs ETV Comparison
AVDL vs ETV Comparison
Compare AVDL & ETV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVDL
- ETV
- Stock Information
- Founded
- AVDL 2015
- ETV 2005
- Country
- AVDL Ireland
- ETV United States
- Employees
- AVDL N/A
- ETV N/A
- Industry
- AVDL Biotechnology: Pharmaceutical Preparations
- ETV Investment Managers
- Sector
- AVDL Health Care
- ETV Finance
- Exchange
- AVDL Nasdaq
- ETV Nasdaq
- Market Cap
- AVDL 1.5B
- ETV 1.7B
- IPO Year
- AVDL 1996
- ETV N/A
- Fundamental
- Price
- AVDL $14.35
- ETV $14.31
- Analyst Decision
- AVDL Strong Buy
- ETV
- Analyst Count
- AVDL 8
- ETV 0
- Target Price
- AVDL $20.88
- ETV N/A
- AVG Volume (30 Days)
- AVDL 1.3M
- ETV 252.5K
- Earning Date
- AVDL 11-11-2025
- ETV 01-01-0001
- Dividend Yield
- AVDL N/A
- ETV 8.75%
- EPS Growth
- AVDL N/A
- ETV N/A
- EPS
- AVDL N/A
- ETV N/A
- Revenue
- AVDL $221,075,000.00
- ETV N/A
- Revenue This Year
- AVDL $64.56
- ETV N/A
- Revenue Next Year
- AVDL $30.60
- ETV N/A
- P/E Ratio
- AVDL N/A
- ETV N/A
- Revenue Growth
- AVDL 132.35
- ETV N/A
- 52 Week Low
- AVDL $6.38
- ETV $11.05
- 52 Week High
- AVDL $16.66
- ETV $13.50
- Technical
- Relative Strength Index (RSI)
- AVDL 43.90
- ETV 63.22
- Support Level
- AVDL $14.85
- ETV $14.06
- Resistance Level
- AVDL $15.58
- ETV $14.32
- Average True Range (ATR)
- AVDL 0.48
- ETV 0.13
- MACD
- AVDL -0.26
- ETV 0.01
- Stochastic Oscillator
- AVDL 12.16
- ETV 87.56
About AVDL Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.
About ETV Eaton Vance Corporation Eaton Vance Tax-Managed Buy-Write Opportunities Fund of Beneficial Interest
Eaton Vance Tax-Managed Buy-Write Opp is a United States-based diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary objective of the fund is capital appreciation. Under normal market conditions, the Fund invests at least 80% of its total assets in a diversified portfolio of common stocks, designated segments of which seek to exceed the total return performance of the S&P 500 and the NASDAQ-100.